Trastuzumab Emtansine (Kadcyla)

trastuzumab emtansine · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Trastuzumab Emtansine (Kadcyla), covering 2014-06-26 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea